Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004136

Enrollment

140

Registered

2019-07-12

Start date

2018-09-03

Completion date

Unknown

Last updated

2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Esmolol. For the ‘C’ group, 20 mL of normal saline was prepared, while the ‘E0.5’, ‘E1’, and ‘E2’ groups had 20 mL of normal saline containing esmolol 0.5 mg/kg, 1 mg/kg, and 2 mg/kg, respectiv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) class I & II who required general anesthesia for elective surgery

Exclusion criteria

Exclusion criteria: Intubation time exceeding 15 seconds, and patients with hypertension, cardiac problems, cervical spine fracture, tumors, or polyps in the upper airway, those with expected airway difficulties, and patients currently using beta blockers were excluded from the study.

Design outcomes

Primary

Measure	Time frame
mean arterial blood pressure;heart rate	—

Secondary

Measure	Time frame
rate-pressure product	—

Countries

Korea, Republic of

Contacts

Public ContactJinku Kang

Soon Chun Hyang University Hospital Cheonan

jin325@gmail.com+82-2-364-5689

Outcome results